The present study showed that Minimal-FSH exposes more than 90% of the patients at the risk of OHSS, so they subjected to GnRH-agonist triggering with triptorelin 0.2 mg s.c and freeze all embryos. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.